Aspergillus in COVID-19 intensive care unit; what is lurking above your head?

Aspergillus COVID-19 SARS-CoV-2 intensive care outbreaks

Journal

Journal of infection prevention
ISSN: 1757-1774
Titre abrégé: J Infect Prev
Pays: England
ID NLM: 101469725

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 23 12 2022
accepted: 04 09 2022
entrez: 24 10 2022
pubmed: 25 10 2022
medline: 25 10 2022
Statut: ppublish

Résumé

Through routine respiratory samples surveillance among COVID-19 patients in the intensive care, three patients with aspergillus were identified in a newly opened general intensive care unit during the second wave of the pandemic. As no previous cases of aspergillus had occurred since the unit had opened. An urgent multidisciplinary outbreak meeting was held. The possible sources of aspergillus infection were explored. The multidisciplinary approach enabled stakeholders from different skills to discuss possible sources and management strategies. Environmental precipitants like air handling units were considered and the overall clinical practice was reviewed. Settle plates were placed around the unit to identify the source. Reports of recent water leaks were also investigated. Growth of aspergillus on a settle plate was identified the potential source above a nurse's station. This was the site of a historic water leak from the ceiling above, that resolved promptly and was not investigated further. Subsequent investigation above the ceiling tiles found pooling of water and mould due to a slow water leak from a pipe. Water leaks in patient areas should be promptly notified to infection prevention. Detailed investigation to ascertain the actual cause of the leak and ensure any remedial work could be carried out swiftly. Outbreak meetings that include diverse people with various expertises (clinical and non-clinical) can enable prompt identification and resolution of contaminated areas to minimise risk to patients and staff. During challenging pandemic periods hospitals must not lose focus on other clusters and outbreaks occurring simultaneously.

Identifiants

pubmed: 36277859
doi: 10.1177/17571774221127548
pii: 10.1177_17571774221127548
pmc: PMC9475376
doi:

Types de publication

Journal Article

Langues

eng

Pagination

278-284

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Lancet Infect Dis. 2021 Jun;21(6):e149-e162
pubmed: 33333012
Microorganisms. 2019 Jan 05;7(1):
pubmed: 30621244
Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135
pubmed: 32396381
WIREs Mech Dis. 2022 Jul 14;:e1577
pubmed: 35835688
Clin Infect Dis. 2015 Aug 1;61(3):433-44
pubmed: 25870328
J Infect Public Health. 2019 Nov - Dec;12(6):904-906
pubmed: 31078493
Med Mycol. 2009;47 Suppl 1:S199-209
pubmed: 19274596

Auteurs

Sue Dailly (S)

Infection Prevention and Control, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Erin Boatswain (E)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Julie Brooks (J)

Infection Prevention and Control, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Glen Campbell (G)

Estates, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Katy Dallow (K)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Ahilanandan Dushianthan (A)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Sarah Glover (S)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Melanie Griffiths (M)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Sanjay Gupta (S)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

James Austin (J)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Robert Chambers (R)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Sarah Jeremiah (S)

Infection Prevention and Control, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Charlotte Morris (C)

Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Nitin Mahobia (N)

Infection Prevention and Control, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Martyn Poxon (M)

Estates, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Alison Rickman (A)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Helen Jaques (H)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Tatshing Yam (T)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Kordo Saeed (K)

Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Classifications MeSH